USFDA okays new antibiotic for highly drug-resistant tuberculosis

Pretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2N3OAvc
via IFTTT